The Evolution and Prognosis of Moyamoya Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Evolution and Prognosis of Moyamoya Disease — Stella

Home/Moyamoya Disease/

View on ClinicalTrials.gov

Recruiting

Back to Moyamoya Disease trials

Trial locations(1 site)

China

Chinese PLA General Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Chinese PLA General Hospital

Collaborators

Beijing Tiantan Hospital

Enrollment target

~300 participants

Started

September 2022

Primary completion

December 2027

Age range

10 Years – 60 Years

Last updated December 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.